Retatrutide 20mg

Retatrutide (LY3437943, often shortened to Reta) is a synthetic peptide studied as an agonist at three hormone receptors: GLP-1, GIP and glucagon. An agonist activates a receptor. These receptors participate in appetite signalling, blood-glucose regulation and energy metabolism.

Published research examines how activating all three pathways affects metabolic responses. This describes the compound studied in the literature, not a demonstrated outcome from this research vial.

Sources: Retatrutide receptor study

Reta and Reta peptide are shorthand for Retatrutide. LY3437943 is its research development code. R3TA and “ratatouille peptide” appear as informal online nicknames. “Reda peptide” also appears in informal discussion, but is not a verified chemical synonym. These labels are not separate compounds or reliable identifiers.

When comparing listings, look for Retatrutide and the labelled vial amount. Pillar supplies Retatrutide for Research Use Only.

Retatrutide is studied at GLP-1, GIP and glucagon receptors. Tirzepatide is studied at GIP and GLP-1 receptors. They are different compounds, not interchangeable names or strengths. Compare the required compound identity first, then vial amount and price.

Compare Retatrutide strengths · Tirzepatide listing

No. This listing supplies a vial of lyophilised Retatrutide research material. It is not a pen, cartridge, ready-made solution or pharmacy product. The price covers the selected vial strength; it does not describe a finished product for personal use.

One vial labelled 20mg of Retatrutide, supplied as lyophilised (freeze-dried) powder. The mg value is the labelled amount in the vial, not a solution concentration.

For Research Use Only, for in vitro laboratory work. Not for human or animal consumption.

The catalogue lists these amounts:

• 10mg: A$144.99 per vial
• 15mg: A$179.99 per vial
• 20mg: A$209.99 per vial
• 30mg: A$269.99 per vial
• 40mg: A$329.99 per vial
• 60mg: A$449.99 per vial

Select a strength above to see its availability and matching batch documentation. A larger vial changes the amount supplied, not the compound’s identity.

Yes. The linked source report for batch 2026-156860 is available in Batch documentation. Match it to the batch on the supplied vial.

A COA records analytical results for the submitted sample. It is not a clinical study or a guarantee of suitability for every experiment.

Pillar Research is an Australian supplier of Retatrutide 20mg for online ordering. This strength is available to add to cart. In-stock orders ship from Australia; see the shipping information at checkout for the dispatch estimate and delivery options.

View the linked batch report before ordering. Free express delivery on orders A$250+. Research Use Only.

Retatrutide 20mg costs A$209.99 per vial from Pillar Research, a trusted Australian supplier. Free express delivery on orders A$250+.

Browse the catalogue to compare research compounds, vial strengths and current prices. Save up to 30% when ordering 10 or more vials of the same compound. Research Use Only.

Browse the catalogue

Yes. In-stock orders ship from Australia with tracking. Free express delivery on orders A$250+ before discounts; A$18.99 below that threshold. Optional signature and parcel protection cost more.

Check this strength's availability and dispatch estimate before ordering. Preorder dispatch estimates are separate from carrier transit times.

Australian shipping information

Follow the storage conditions and expiry on the supplied label and any accompanying handling documentation. Keep the original container and batch identification.

If a temperature range or shelf life is missing, request it before use. A general product-page answer cannot establish stability after a laboratory preparation is made.